<?xml version="1.0"?>
<rss version="2.0">
	<channel>
		<title>Drug News in Central Nervous System area.</title>
		<link>http://www.lifescience-online.com/</link>
		<description>News Feed Powered by Lifescience-online.com</description>
		<language>en-us</language>
		<pubDate>Wed, 08 Feb 2012 04:12:06 +0100</pubDate>
		<lastBuildDate>Wed, 08 Feb 2012 04:12:06 +0100</lastBuildDate>
		<category>News</category>		

		<image>
			<title>Lifescience-online</title>
			<url>http://rss.lifescience-online.com/images/logo.gif</url>
			<link>http://www.lifescience-online.com/</link>
			<width></width>
			<height></height>
			<description>Lifescience-online</description>
		</image>

		<item>
			<title>Lannett Receives FDA Approval for ANDA Supplement for Phentermine HCL Capsules, 15 mg</title>
			<link>http://www.lifescience-online.com/Lannett_Receives_FDA_Approval_for_ANDA_Supplement_,30794.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/lannett_co,835.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>LANNETT CO INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/PHENTERMINE_HYDROCHLORIDE,10276.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>PHENTERMINE HYDROCHLORIDE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 30 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>StemCells, Inc. Announces Publication of Preclinical Data Demonstrating Its Human Neural Stem Cells Preserve Vision</title>
			<link>http://www.lifescience-online.com/StemCells__Inc__Announces_Publication_of_Preclinic,30788.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/stemcells,6760.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>STEMCELLS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/HUCNS-SC,21903.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>HUCNS-SC</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Sun, 29 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Ipsen Acknowledges Tanakan(R) Delisting in France</title>
			<link>http://www.lifescience-online.com/Ipsen_Acknowledges_Tanakan__Delisting_in_France,30728.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/ipsen,2406.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>IPSEN</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/EGB-761,2633.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>EGB-761</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 26 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Apricus Biosciences Expands Commercial Oncology Offerings Through Agreement With Pediatrx for U.S. Co-Promotion of GRANISOL(R) (Granisetron) Oral Solution and AQUORAL(TM) Spray and Purchase of Non-U.S. Rights to GRANISOL(R)</title>
			<link>http://www.lifescience-online.com/Apricus_Biosciences_Expands_Commercial_Oncology_Of,30752.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/3.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/apricus_biosciences,949.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>APRICUS BIOSCIENCES INC</u></font></a><br /><a href='http://www.lifescience-online.com/pediatrx,14810.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>PEDIATRX INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/GRANISETRON_HYDROCHLORIDE,10806.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>GRANISETRON HYDROCHLORIDE</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Thu, 26 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Vanda Pharmaceuticals, Inc. (VNDA) Release: Initial Clinical Data Reveal Potential of Tasimelteon to Reset the Body Clock in Non-24-Hour Sleep-Wake Disorder</title>
			<link>http://www.lifescience-online.com/Vanda_Pharmaceuticals__Inc___VNDA__Release__Initia,30741.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/vanda_pharmaceuticals,9215.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>VANDA PHARMACEUTICALS INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/TASIMELTEON,20385.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>TASIMELTEON</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Wed, 25 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>UCB announces FDA approval for Keppra(R) in infants and children from one month of age with partial onset seizures</title>
			<link>http://www.lifescience-online.com/UCB_announces_FDA_approval_for_Keppra__in_infants_,30713.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/0.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/ucb_sa,5332.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>UCB SA</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/LEVETIRACETAM,8678.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>LEVETIRACETAM</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 24 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Neurocrine Biosciences, Inc. (NBIX) Announces The FDA Has Granted Fast Track Designation For VMAT2 Inhibitor NBI-98854</title>
			<link>http://www.lifescience-online.com/Neurocrine_Biosciences__Inc___NBIX__Announces_The_,30739.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/2.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/neurocrine_biosciences,944.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>NEUROCRINE BIOSCIENCES INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/NBI-98854,24912.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>NBI-98854</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Tue, 24 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

		<item>
			<title>Depomed Announces Initiation of Phase 2 Clinical Study in Parkinson&#039;s Disease</title>
			<link>http://www.lifescience-online.com/Depomed_Announces_Initiation_of_Phase_2_Clinical_S,30760.html?portalPage=Lifescience+Today.News</link>
			<description><![CDATA[
<div valign='top' style='position:absolute;'><img align='right' src='http://static.lifescience-online.com/commonimages/news/5/1.gif' /></div><dl><dt><b>Area</b> :</dt><dd>Central Nervous System</dd><br /><dt><b>Category</b> :</dt><dd>Scientific - Pipeline - Regulatory</dd><br /><dt><b>Related companies</b> :</dt><dd><a href='http://www.lifescience-online.com/depomed,356.html?portalPage=Business.Key+Players'><font color='#003366'><u color='#003366'>DEPOMED INC</u></font></a></dd><br /><dt><b>Related drugs</b> :</dt><dd><a href='http://www.lifescience-online.com/CARBIDOPA_+_LEVODOPA,10321.html?portalPage=Drugs'><font color='#003366'><u color='#003366'>CARBIDOPA + LEVODOPA</u></font></a></dd><br /><br /></dl>
]]></description>
			<pubDate>Mon, 23 Jan 2012 23:00:00 GMT</pubDate>
			<category>News</category>
		</item>

	</channel>
</rss>
